Clough Capital Partners L P Moderna, Inc. Transaction History

Clough Capital Partners L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $10.9 Million - $23.8 Million	-49,040 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $1.7 Million - $3.08 Million	13,118 Added 36.52%	49,040 $11.5 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $2.09 Million - $3.56 Million	-19,140 Reduced 34.76%	35,922 $4.7 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $14.6 Million - $37.7 Million	-222,240 Reduced 80.14%	55,062 $5.75 Million
Q3 2020 Nov 17, 2020	BUY	$54.34 - $94.85 $8.01 Million - $14 Million	147,472 Added 113.59%	277,302 $19.6 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $3.85 Million - $10.4 Million	129,830 New	129,830 $8.34 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.